Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
- PMID: 28533211
- PMCID: PMC5494529
- DOI: 10.15252/emmm.201707895
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
Abstract
Expression of concern for
-
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.EMBO Mol Med. 2016 Nov 2;8(11):1265-1288. doi: 10.15252/emmm.201505889. Print 2016 Nov. EMBO Mol Med. 2016. PMID: 27742718 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources